Anti-TNFα therapy improves survival and ameliorates the pathophysiologic sequelae in acute pancreatitis in the rat

https://doi.org/10.1016/S0002-9610(97)89568-2Get rights and content

Background

Elevated levels of tumor necrosis factor-alpha (TNFα) have been measured in a lethal model of acute pancreatitis (AP) and may contribute to the pathophysiologic sequelae of the disease.

Methods

To determine the significance of anti-TNFα therapy on survival and disease manifestations in a clinically relevant model of AP, a rat model was developed using a retrograde pancreatic ductal infusion of bile. Animals were randomized to no treatment (n = 30) or treatment with anti-TNFα antibody 15 minutes prior to induction of AP (n = 30). Five treated and 5 untreated rats were killed at various time periods up to 72 hours to provide temporal characterization of TNFα activity in AP.

Results

A burst of TNFα activity in the serum of untreated pancreatitis animals between 1 and 3 hours after induction of the disease is prevented by pretreatment with anti-TNFα antibody.

Conclusions

These findings provide a plausible mechanism for the improvement in biochemical and histologic parameters as well as in overall survival in an experimental model of acute pancreatitis in the rat.

References (38)

  • BilchikAJ et al.

    Experimental models of acute pancreatitis

    J Surg Res

    (1990)
  • MichieHR et al.

    Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings

    Surgery

    (1988)
  • TraceyKJ et al.

    Shock and tissue injury induced by recombinant human cachectin

    Science

    (1986)
  • ImagawaDK et al.

    The role of tumor necrosis factor in allograft rejection: II. Evidence that antibody therapy against tumor necrosis factor-alpha and lymphotoxin enhances cardiac allograft survival in rats

    Transplantation

    (1990)
  • ShalabyMR et al.

    Prevention of the graft-versus-host reaction in newborn mice by antibodies to tumor necrosis factor-alpha

    Transplantation

    (1989)
  • PiguetPF et al.

    Tumor necrosis factor/cachectin is an effector of skin and gut lesions in the acute phase of graft-vs-host disease

    J Exp Med

    (1987)
  • WindsorAG et al.

    Tumor necrosis factor-alpha blockade prevents neutrophil CD18 receptor upregulation and attenuates acute lung injury in porcine sepsis without inhibition of neutrophil oxygen radical generation

    J Clin Invest

    (1993)
  • SuterPM et al.

    High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis

    Am Rev Respir Dis

    (1992)
  • Ferrari-BalivieraE et al.

    Tumor necrosis factor induces adult respiratory distress syndrome in rats

    Arch Surg

    (1989)
  • Cited by (140)

    • Ligustrazine alleviates acute pancreatitis by accelerating acinar cell apoptosis at early phase via the suppression of p38 and Erk MAPK pathways

      2016, Biomedicine and Pharmacotherapy
      Citation Excerpt :

      A plentiful of studies showed pro-inflammatory cytokines especially TNF-α, IL-1β and IL-6 were main reasons resulting in part damage of pancreas and progressing to systemic disease [18]. In pancreatitis, the levels of TNF-α, IL-1β and IL-6 were upregulated and the blockage on their increase can reduce the process of disease development [19,20]. Therefore, we determined the levels of TNF-α, IL-1β and IL-6 in acinar cells before and after the induction of AP.

    View all citing articles on Scopus
    View full text